Selected article for: "central nervous system and CNS present"
Author: Rezaeitalab, Fariborz; Jamehdar, Saeid Amel; Sepehrinezhad, Ali; Rashidnezhad, Azra; Moradi, Fereydoun; Sadat Esmaeli Fard, Fateme; Hasanzadeh, Sepideh; Etezad Razavi, Mohammad; Gorji, Ali; Sahab Negah, Sajad
Title: Detection of SARS-coronavirus-2 in the central nervous system of patients with severe acute respiratory syndrome and seizures
  • Cord-id: qv7tbqpf
  • Document date: 2021_3_1
    • ID: qv7tbqpf
    Snippet: This study was designed to evaluate whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can directly target the central nervous system (CNS). We present four patients suffering from the loss of consciousness and seizure during the clinical course of COVID-19 infection. In addition to positive nasopharyngeal swab tests, SARS-CoV-2 has been detected in their cerebrospinal fluid. This report indicates the neuroinvasive potential of SARS-CoV-2, suggesting the ability of this virus t
    Document: This study was designed to evaluate whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can directly target the central nervous system (CNS). We present four patients suffering from the loss of consciousness and seizure during the clinical course of COVID-19 infection. In addition to positive nasopharyngeal swab tests, SARS-CoV-2 has been detected in their cerebrospinal fluid. This report indicates the neuroinvasive potential of SARS-CoV-2, suggesting the ability of this virus to spread from the respiratory tract to the CNS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13365-020-00938-w.

    Search related documents:
    Co phrase search for related documents
    • abnormal protein and admission day: 1, 2
    • abnormal protein and lymphocyte count: 1, 2, 3, 4, 5
    • abnormal protein level and lymphocyte count: 1
    • acute respiratory syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and loss seizure: 1, 2, 3
    • acute respiratory syndrome and lung ground glass consolidation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and lung pleural effusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • additional evidence and admission day: 1
    • additional evidence and lymphocyte count: 1
    • admission day and lung ground glass consolidation: 1, 2
    • admission day and lung pleural effusion: 1
    • admission day and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lung ground glass consolidation and lymphocyte count: 1, 2, 3, 4, 5, 6